Literature DB >> 8435942

Herpetic vaginitis in 1993.

C G Prober1.   

Abstract

Substantial advances have been made in our understanding of HSV and genital herpes. The molecular biology of viral structure and function and the pathogenesis of infection have been elucidated to a large degree, and epidemiologic investigations, based on reliable type-specific assays, have been done. Diagnostic techniques have been refined, and the value of therapy has been defined. Currently, management strategies for pregnant women and their neonates are based on data rather than hypothesis, and rational counseling is feasible. The next major advance in the field would be the availability of a safe and effective vaccine, the development and investigation of which is being pursued vigorously.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8435942     DOI: 10.1097/00003081-199303000-00023

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  2 in total

1.  Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.

Authors:  L L Scott; L M Hollier; D McIntire; P J Sanchez; G L Jackson; G D Wendel
Journal:  Infect Dis Obstet Gynecol       Date:  2001

2.  Acyclovir suppression to prevent recurrent genital herpes at delivery.

Authors:  L L Scott; L M Hollier; D McIntire; P J Sanchez; G L Jackson; G D Wendel
Journal:  Infect Dis Obstet Gynecol       Date:  2002
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.